Endo International

From WikiMD's WELLNESSPEDIA

(Redirected from Qualitest)

Overview[edit]

Endo International is a global specialty pharmaceutical company that develops, manufactures, and distributes a broad range of branded and generic pharmaceutical products. The company is headquartered in Dublin, Ireland, and has operations in various countries around the world.

History[edit]

Endo International was founded in 1997 as a result of a management buyout from DuPont Merck. The company initially focused on pain management and expanded its portfolio through strategic acquisitions and product development. Over the years, Endo has acquired several companies, including Paladin Labs, Par Pharmaceutical, and Auxilium Pharmaceuticals, to enhance its product offerings and market presence.

Business Segments[edit]

Endo International operates through several business segments:

Branded Pharmaceuticals[edit]

This segment includes the development and marketing of branded prescription products. Key therapeutic areas include pain management, urology, and endocrinology.

Sterile Injectables[edit]

Endo's sterile injectables segment focuses on the production and distribution of injectable products, including generic and branded formulations.

Generic Pharmaceuticals[edit]

The generic pharmaceuticals segment involves the development, manufacturing, and marketing of generic drugs. This segment was significantly expanded through the acquisition of Par Pharmaceutical.

Products[edit]

Endo International offers a wide range of products across various therapeutic areas. Some of the notable products include:

  • [[Opana ER - An extended-release opioid analgesic for pain management.
  • [[Xiaflex - A collagenase clostridium histolyticum injection for the treatment of Dupuytren's contracture and Peyronie's disease.
  • [[Vasostrict - A vasopressin injection used to increase blood pressure in adults with vasodilatory shock.

Controversies[edit]

Endo International has faced several controversies, particularly related to its opioid products. The company has been involved in litigation concerning the marketing and distribution of opioid medications, which have been linked to the opioid epidemic in the United States.

Related Pages[edit]


Pharmaceutical companies
List of pharmaceutical companies
Pharmaceutical industry
Related topics

Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.

Retrieved from "https://wikimd.org/index.php?title=Endo_International&oldid=6614603"